Tetrahydrothiophene derivatives
AssigneeSanten Pharmaceutical Co., Ltd.
InventorsShiro Mita, Yoichi Kawashima, Nobuharu Kato, Hiroshi Suhara, Koji Yoneda, Masataka Morishita
Life of this patent
Estimating the term…
Loading patent…
AssigneeSanten Pharmaceutical Co., Ltd.
InventorsShiro Mita, Yoichi Kawashima, Nobuharu Kato, Hiroshi Suhara, Koji Yoneda, Masataka Morishita
Estimating the term…
A compound of the formula [I] and pharmaceutically acceptable salts thereof; and a synthetic intermediate represented by the formula [II] and pharmaceutically acceptable salts thereof, ##STR1## wherein R 1 is hydrogen or lower alkyl; R 2 is hydrogen or a protective group of thiol; R 3 is hydroxy, a remainder of ester group or a remainder of amido group; A is straight or branched lower alkylene, and the sulfur atom in the side chain may be directly join with --CO-- to conform a thiolactone ring. The compounds of this invention have excellent thymulin-like activities and are expected to be useful for treatment of various immune disorders such as immunodeficiency and autoimmune diseases.
A compound of the formula (I) and pharmaceutically acceptable salts thereof, ##STR11## wherein R.sup.1 is hydrogen or lower alkyl;
4-carboxy-2-mercaptomethyltetrahydrothiophene.
4-carboxy-2-(1-mercapto-1-methylethyl)tetrahydrothiophene.
(2R,4R)-4-carboxy-2-mercaptomethyltetrahydrothiophene.
A compound of the formula (II) and pharmaceutically acceptable salts thereof, ##STR16## wherein R.sup.1 is hydrogen or lower alkyl;
Dependencies are inferred from the claim text.